Nothing Special   »   [go: up one dir, main page]

DE69722615D1 - Zusammensetzungen die ein anti-pilz agens und ein acetat-puffer enthalten - Google Patents

Zusammensetzungen die ein anti-pilz agens und ein acetat-puffer enthalten

Info

Publication number
DE69722615D1
DE69722615D1 DE69722615T DE69722615T DE69722615D1 DE 69722615 D1 DE69722615 D1 DE 69722615D1 DE 69722615 T DE69722615 T DE 69722615T DE 69722615 T DE69722615 T DE 69722615T DE 69722615 D1 DE69722615 D1 DE 69722615D1
Authority
DE
Germany
Prior art keywords
compositions containing
acetate buffer
mushroom
agent
mushroom agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69722615T
Other languages
English (en)
Other versions
DE69722615T2 (de
Inventor
J Nerurkar
A Hunke
J Kaufman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26309400&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69722615(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9611006.9A external-priority patent/GB9611006D0/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of DE69722615D1 publication Critical patent/DE69722615D1/de
Application granted granted Critical
Publication of DE69722615T2 publication Critical patent/DE69722615T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
DE69722615T 1996-04-19 1997-04-15 Zusammensetzungen die ein anti-pilz agens und ein acetat-puffer enthalten Expired - Lifetime DE69722615T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US1563896P 1996-04-19 1996-04-19
US15638P 1996-04-19
GBGB9611006.9A GB9611006D0 (en) 1996-05-24 1996-05-24 Antifungal compositions
GB9611006 1996-05-24
PCT/US1997/006284 WO1997039763A1 (en) 1996-04-19 1997-04-15 Compositions comprising antifungal agent and acetate buffer

Publications (2)

Publication Number Publication Date
DE69722615D1 true DE69722615D1 (de) 2003-07-10
DE69722615T2 DE69722615T2 (de) 2004-04-29

Family

ID=26309400

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69722615T Expired - Lifetime DE69722615T2 (de) 1996-04-19 1997-04-15 Zusammensetzungen die ein anti-pilz agens und ein acetat-puffer enthalten

Country Status (36)

Country Link
EP (1) EP0904098B1 (de)
JP (1) JP3258672B2 (de)
CN (1) CN1132624C (de)
AR (1) AR006598A1 (de)
AT (1) ATE241999T1 (de)
AU (1) AU706250B2 (de)
BG (1) BG64272B1 (de)
BR (2) BR9708706B8 (de)
CA (1) CA2251928C (de)
CO (1) CO4940486A1 (de)
CY (1) CY2374B1 (de)
CZ (1) CZ289361B6 (de)
DE (1) DE69722615T2 (de)
DK (1) DK0904098T3 (de)
DZ (1) DZ2205A1 (de)
EA (1) EA001386B1 (de)
EE (1) EE04265B1 (de)
ES (1) ES2198569T3 (de)
HK (1) HK1020873A1 (de)
HR (1) HRP970201B1 (de)
HU (1) HU228296B1 (de)
ID (1) ID16643A (de)
IL (1) IL126479A (de)
IS (1) IS2159B (de)
MY (1) MY126305A (de)
NO (1) NO321954B1 (de)
NZ (1) NZ332156A (de)
PE (1) PE63998A1 (de)
PL (1) PL187294B1 (de)
PT (1) PT904098E (de)
RS (1) RS49566B (de)
SA (1) SA97180104B1 (de)
SK (1) SK281969B6 (de)
TR (1) TR199802102T2 (de)
UA (1) UA55409C2 (de)
WO (1) WO1997039763A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL145185A0 (en) * 1999-03-03 2002-06-30 Lilly Co Eli Echinocandin pharmaceutical formulations containing micelle-forming surfactants
TWI233805B (en) * 1999-07-01 2005-06-11 Fujisawa Pharmaceutical Co Stabilized pharmaceutical composition in lyophilized form as antifungal agent
CN101516387B (zh) * 2006-07-26 2014-06-04 桑多斯股份公司 卡泊芬净制剂
BRPI0715113A2 (pt) * 2006-07-26 2013-06-04 Sandoz Ag Sandoz Sa Sandoz Ltd formulaÇço de caspofungina
US20100137197A1 (en) 2007-06-26 2010-06-03 Sachin Mittal Lyophilized anti-fungal composition
US8048853B2 (en) 2008-06-13 2011-11-01 Xellia Pharmaceuticals Aps Process for preparing pharmaceutical compound and intermediates thereof
US20100256074A1 (en) * 2008-06-25 2010-10-07 Chaim Eidelman Processes for preparing high purity aza cyclohexapeptides
WO2010108637A1 (en) * 2009-03-27 2010-09-30 Axellia Pharmaceuticals Aps Crystalline compound
CN102219832B (zh) * 2010-04-15 2013-08-21 上海天伟生物制药有限公司 一种氮杂环六肽或其盐的纯化方法
CN102367267B (zh) * 2010-11-10 2013-09-04 上海天伟生物制药有限公司 一种卡泊芬净的制备方法
CN102367269B (zh) * 2010-11-10 2013-11-06 上海天伟生物制药有限公司 一种卡泊芬净类似物及其制备方法和用途
CN102367268B (zh) * 2010-11-10 2013-11-06 上海天伟生物制药有限公司 一种卡泊芬净类似物及其用途
CN102614493B (zh) * 2011-01-31 2013-12-11 上海天伟生物制药有限公司 一种含有棘白菌素类抗真菌剂卡泊芬净的液体药用组合物
CN102488888B (zh) * 2011-01-31 2014-07-30 上海天伟生物制药有限公司 一种含有棘白菌素类抗真菌剂的药用组合物及其制备方法和用途
CN102488887B (zh) * 2011-01-31 2014-06-18 上海天伟生物制药有限公司 一种含有棘白菌素类抗真菌剂卡泊芬净的药用组合物及其制备方法和用途
CN102166186A (zh) * 2011-04-18 2011-08-31 深圳市健元医药科技有限公司 一种更加稳定的氮杂环己肽类制剂
CN102488889B (zh) * 2011-09-26 2014-01-22 上海天伟生物制药有限公司 一种低杂质含量的卡泊芬净制剂及其制备方法和用途
CN102488886B (zh) * 2011-09-26 2014-03-26 上海天伟生物制药有限公司 一种低杂质含量的卡泊芬净制剂及其制备方法和用途
CN103212059A (zh) * 2012-01-18 2013-07-24 江苏恒瑞医药股份有限公司 含有抗真菌药物和乳酸盐缓冲液的组合物
MX2014011299A (es) * 2012-03-19 2015-05-11 Cidara Therapeutics Inc Regimenes de dosificacion para compuestos de la clase de las equinocandinas.
EP2992003B1 (de) 2013-05-02 2017-01-25 DSM Sinochem Pharmaceuticals Netherlands B.V. Verfahren zur isolierung von caspofungin
PL3058958T3 (pl) 2015-02-23 2019-02-28 Selectchemie Ag Kompozycja anidulafunginy
EP4268896A3 (de) 2016-03-16 2024-01-03 Cidara Therapeutics, Inc. Dosierpläne zur behandlung von pilzinfektionen
EP3651801A4 (de) 2017-07-12 2021-04-07 Cidara Therapeutics, Inc. Zusammensetzungen und verfahren zur behandlung von pilzinfektionen
CN109721641B (zh) * 2017-10-31 2021-08-03 鲁南制药集团股份有限公司 一种卡泊芬净的合成方法
CN113801202B (zh) * 2020-06-15 2024-11-05 杭州中美华东制药有限公司 一种醋酸卡泊芬净杂质g的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1234383A (en) * 1982-03-17 1983-09-22 Inter-Yeda Ltd. Interferon stabilised with polyvinyl-pyrrolidone
WO1989011297A1 (en) * 1988-05-27 1989-11-30 Centocor, Inc. Freeze-dried formulation for antibody products
US5939384A (en) * 1991-10-01 1999-08-17 Merck & Co., Inc. Cyclohexapeptidyl propanolamine compounds
DE4305225A1 (de) * 1993-02-19 1994-08-25 Asta Medica Ag Neues Herstellverfahren für Cetrorelix Lyophilisat
US5378804A (en) * 1993-03-16 1995-01-03 Merck & Co., Inc. Aza cyclohexapeptide compounds
IL109350A (en) * 1993-05-12 2001-01-28 Genentech Inc Stable liquid preparations of gamma interferon

Also Published As

Publication number Publication date
AU706250B2 (en) 1999-06-10
DK0904098T3 (da) 2003-09-15
HRP970201B1 (en) 2002-06-30
CY2374B1 (en) 2004-06-04
JPH11509555A (ja) 1999-08-24
IL126479A (en) 2006-08-01
EA001386B1 (ru) 2001-02-26
AU2731197A (en) 1997-11-12
BR9708706B1 (pt) 2013-08-06
CZ334798A3 (cs) 1999-06-16
HK1020873A1 (en) 2000-05-26
SA97180104B1 (ar) 2006-02-08
EE04265B1 (et) 2004-04-15
CN1132624C (zh) 2003-12-31
NO321954B1 (no) 2006-07-31
AR006598A1 (es) 1999-09-08
NZ332156A (en) 2000-04-28
WO1997039763A1 (en) 1997-10-30
IS2159B (is) 2006-11-15
DZ2205A1 (fr) 2002-12-03
CA2251928C (en) 2003-06-17
BG64272B1 (bg) 2004-08-31
HU228296B1 (en) 2013-03-28
HUP9901586A3 (en) 2002-05-28
PE63998A1 (es) 1998-10-30
RS49566B (sr) 2007-04-10
CO4940486A1 (es) 2000-07-24
EA199800938A1 (ru) 1999-04-29
TR199802102T2 (xx) 1999-01-18
UA55409C2 (uk) 2003-04-15
BR9708706B8 (pt) 2019-03-06
EP0904098A1 (de) 1999-03-31
YU45098A (sh) 1999-07-28
NO984860L (no) 1998-12-18
CZ289361B6 (cs) 2002-01-16
SK281969B6 (sk) 2001-09-11
SK144898A3 (en) 1999-05-07
CA2251928A1 (en) 1997-10-30
BRPI9708706C8 (pt) 2021-01-05
HRP970201A2 (en) 1998-08-31
ID16643A (id) 1997-10-23
JP3258672B2 (ja) 2002-02-18
PL329442A1 (en) 1999-03-29
NO984860D0 (no) 1998-10-16
IS4858A (is) 1998-10-02
BR9708706A (pt) 1999-08-03
IL126479A0 (en) 1999-08-17
BG102857A (en) 1999-09-30
PT904098E (pt) 2003-09-30
ATE241999T1 (de) 2003-06-15
ES2198569T3 (es) 2004-02-01
MY126305A (en) 2006-09-29
EE9800345A (et) 1999-04-15
EP0904098B1 (de) 2003-06-04
DE69722615T2 (de) 2004-04-29
CN1222082A (zh) 1999-07-07
HUP9901586A2 (hu) 1999-08-30
PL187294B1 (pl) 2004-06-30

Similar Documents

Publication Publication Date Title
DE69722615D1 (de) Zusammensetzungen die ein anti-pilz agens und ein acetat-puffer enthalten
GB9422571D0 (en) Haemorrihoidal compositions and method of use
IL114759A (en) Benzoxazole derivatives and pharmaceutical compositions containing them
EP0799495A4 (de) Silizium-germanium-kohlenstoff-verbindung und dazugehörende prozesse
HU9602188D0 (en) Novel carbamate derivative and medicinal composition containing the same
DE69711640D1 (de) Naphthopyrane, zusammensetzungen und artikel die diese enthalten
DE69701498D1 (de) Fluoroelastomer und seine härtbare Zusammensetzung
IL135366A0 (en) Substituted benzoxazoles and pharmaceutical compositions containing the same
DE69305615D1 (de) Parfümiertes mittel
DE69815842T2 (de) Riechstofffixiermittel die polyvinylpyrrolidon und hydroxylcellulose enthalten
ZA971964B (en) Azolobenzazepine derivatives and compositions and method of use thereof.
DE69842237D1 (de) Azeotropische Zusammensetzungen enthaltend 1,1,1,2,3,3,3-Heptafluorpropan und Verfahren, die diese Zusammensetzungen verwenden
IS4466A (is) Samsetning og meðhöndlun fyrir heila- og mænusigg
ZA961948B (en) 6-aryl pyrazoloÚ3,4-d¾pyrimidin-4-ones and compositions and methods of use thereof
KR970702890A (ko) 플루오로실리콘 화합물과 이 화합물을 함유하는 조성물(fluorosilicone compound and composition containing the same)
KR960705557A (ko) 항미생물 방법 및 화장품 조성물(antimicrobial method and cosmetic composition)
DE69125593D1 (de) Dynamisches RAM und Verfahren zu seiner Herstellung
FR2754179B1 (fr) Nouvelle composition hormononale et son utilisation
DE69710623D1 (de) Clathraten und essbare Zusammenzetzungen die diese enthalten
GB9415420D0 (en) Cosmetic compositions and processes for manufacture thereof
ITMI931125A0 (it) Composizioni dentarie e di ricostruzione
IL112564A0 (en) 1-beta-methyl-carbapenems and compositions containing them
DE69530633D1 (de) Thyristor und Verfahren zu seiner Herstellung
FR2739382B1 (fr) Fraction ribosomale et composition la contenant
GB9006671D0 (en) Diagnostic method and compositions

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: MERCK SHARP & DOHME CORP., NEW JERSEY, N.J., US

R081 Change of applicant/patentee

Ref document number: 904098

Country of ref document: EP

Owner name: SCHERING CORPORATION, US

Free format text: FORMER OWNER: MERCK SHARP & DOHME CORP., 07065-0900 RAHWAY, US

Effective date: 20121213

R082 Change of representative

Ref document number: 904098

Country of ref document: EP

Representative=s name: ABITZ & PARTNER, DE

Effective date: 20121213